Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.700
+0.004 (0.50%)
Nov 21, 2024, 11:14 AM EST - Market open
Gossamer Bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Gossamer Bio stock have an average target of 9.20, with a low estimate of 4.00 and a high estimate of 15. The average target predicts an increase of 1,214.29% from the current stock price of 0.70.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Gossamer Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,328.57% | Nov 11, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,328.57% | Sep 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +1,328.57% | Aug 30, 2024 |
| Wedbush | Wedbush | Buy Reiterates $4 | Buy | Reiterates | $4 | +471.43% | Aug 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $9 | Buy | Initiates | $9 | +1,185.71% | Jun 25, 2024 |
Financial Forecast
Revenue This Year
113.77M
Revenue Next Year
18.64M
from 113.77M
Decreased by -83.61%
EPS This Year
-0.29
from -1.18
EPS Next Year
-0.70
from -0.29
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 179.8M | 43.7M | 126.4M | ||
| Avg | 113.8M | 18.6M | 48.5M | ||
| Low | 93.9M | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | -61.6% | 578.1% | ||
| Avg | - | -83.6% | 160.0% | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.07 | -0.54 | 0.25 | ||
| Avg | -0.29 | -0.70 | -0.41 | ||
| Low | -0.42 | -1.07 | -0.91 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.